Rule out Screening for Undiagnosed Dementia and Alzheimer’s Disease Using an EHR Based Machine Learning Solution by Stephan, Branum et al.
SMU Data Science Review 
Volume 5 Number 1 Article 5 
2021 
Rule out Screening for Undiagnosed Dementia and Alzheimer’s 
Disease Using an EHR Based Machine Learning Solution 
Branum Stephan 
Southern Methodist University, bstephan@smu.edu 
David A. Julovich 
Southern Methodist University and University of North Texas Health Science Center at Fort Worth, 
david.julovich@unthsc.edu 
Dustin Bracy 
Southern Methodist University, dbracy@smu.edu 
Jeff Nguyen 
Southern Methodist University, jeffn@smu.edu 
Follow this and additional works at: https://scholar.smu.edu/datasciencereview 
 Part of the Analytical, Diagnostic and Therapeutic Techniques and Equipment Commons, Community 
Health and Preventive Medicine Commons, Geriatrics Commons, Neurology Commons, and the 
Neurosciences Commons 
Recommended Citation 
Stephan, Branum; Julovich, David A.; Bracy, Dustin; and Nguyen, Jeff (2021) "Rule out Screening for 
Undiagnosed Dementia and Alzheimer’s Disease Using an EHR Based Machine Learning Solution," SMU 
Data Science Review: Vol. 5 : No. 1 , Article 5. 
Available at: https://scholar.smu.edu/datasciencereview/vol5/iss1/5 
This Article is brought to you for free and open access by SMU Scholar. It has been accepted for inclusion in SMU 
Data Science Review by an authorized administrator of SMU Scholar. For more information, please visit 
http://digitalrepository.smu.edu. 
Rule out Screening for Undiagnosed Dementia and 
Alzheimer’s Disease Using an EHR Based Machine 
Learning Solution  
Branum Stephan, B.S.1, David A. Julovich, B.S.1,2, Dustin Bracy, B.S.1,  Jeff 
Nguyen, B.S.1,  
1 Master of Science in Data Science, Southern Methodist University, 
 Dallas, TX 75275 USA 
2 Institute for Translational Research - Department of Pharmacology & Neuroscience, 
University of North Texas Health Science Center  
Fort Worth, TX USA 
{bstephan, djulovich, dbracy, jeffn}@smu.edu 
Abstract. Current detection methods for Dementia and Alzheimer’s disease 
include cerebral spinal fluid (CSF) markers and/or the use of positron emission 
tomography (PET) imaging, both being high-cost, highly invasive testing 
methods. The need for low-cost, minimally invasive methods to prescreen 
individuals for cognitive impairment has been a challenge for many years. 
Today’s costs associated with an annual screen for all adults 65 and above using 
current methods (CSF, PET) reach well beyond trillions of dollars per year. 
Motivated by the limited accessibly and high costs, an alternative tool presented 
within this paper demonstrates an effective rule out screening for Dementia and 
Alzheimer’s disease. Leveraging Electronic Health Records (EHR) data, low-
cost computing, modern statistical modeling, and useable Machine Learning 
algorithms were able to derive a screening tool that effectively detects 98 percent 
of individuals without Dementia and Alzheimer’s disease. Approximately 43,000 
EHR patient records’ totaling 5,000 patients from the University of North Texas 
Health Science Center were evaluated using this new rule out screening method, 
which consists of traditional Machine Learning models: Random Forest, 
AdaBoost, SVM combined with the application of Natural Language Processing 
of physician’s notes. The findings from this study help define a new paradigm in 
medical practice where an effective rule out screening method for Dementia and 
Alzheimer’s disease can be used as an initial screening tool. This study 
effectively cuts the cost of current detection methods by 75 percent, gives access 
to all adults age 65 and above while still leaving expensive methods as secondary 
lines of detection. 
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1   Introduction 
For over 20 years, there has been the need for low-cost, minimally invasive Dementia 
and Alzheimer’s disease screening methods for patients to better determine who does 
not have the disease. By identifying those not at-risk from those at-risk within differing 
healthcare environments, it is now possible to generate savings and better utilize current 
high-cost testing methods (CSF/PET). A rule out approach greatly reduces the number 
of patients escalated for higher cost neurodiagnostic testing. Rule out screening of 
Dementia and Alzheimer’s disease gives patients peace of mind because the results 
indicate the disease is not present. While at-risk patients are not diagnosed, they would 
be referred on for additional neurodiagnostic testing; consistent with other screening 
methods currently employed in other areas such as oncology.  
Machine Learning models trained on EHR data using unstructured doctor’s notes 
can provide a useful method for ruling out those without Dementia and Alzheimer’s 
disease within a traditional clinic and hospital setting. Such an approach, to date, has 
not been evaluated particularly with advanced statistical analytic methods (i.e. Machine 
Learning). Despite the potential for the proposed applied Machine Learning solutions, 
there are industry-wide hurdles regarding access to data that needs to be overcome 
when using Electronic Health Records.  
The Department of Health & Human Services (HHS) is committed to increasing 
interoperability including the ability to exchange, interpret, and use medical data 
cohesively, across all healthcare settings, servicers, and providers. As of 2015, 96 
percent of hospitals and healthcare providers along with 78 percent of office-based 
physicians use digital records [21]. The current disconnects in customer records is a 
major issue. Neither patients nor doctors have consistent access to a patient’s entire 
record history from varying institutions. Therefore, disconnections exist between the 
different institutions, which means there not consistent data standards and or means. of 
data collection. Unique EHR systems will require custom installation and setup of the 
rule out tool within each environment. 
A low-cost, highly accessible screening tool is presented here. EHR records can be 
successfully utilized and quickly assembled into a functional resource that is used to 
screen for Dementia and Alzheimer’s disease. The addition of Natural Language 
Processing shows great promise as a new component to the screening tool, creating 
untapped features that are highly important and produce better model predictions. The 
findings discussed within add value to current medical and research literature by 
demonstrating a screening tool that effectively detects individuals without Dementia 
and Alzheimer’s disease for patients that visit their doctor. 
2   Alzheimer’s disease 
As an overview, Alzheimer’s disease is a neurodegenerative disease that is particularly 
common in the senior population of 50 years and above. The disease was discovered in 
1906 by Dr. Alois Alzheimer during an inspection of neural tissue from a deceased 
elderly woman who had reported unusual mental illnesses. Some of her most notable 
characteristics were memory loss, language difficulty, and erratic behavior. Physical 
2
SMU Data Science Review, Vol. 5 [2021], No. 1, Art. 5
https://scholar.smu.edu/datasciencereview/vol5/iss1/5
characteristics of her brain included abnormal amyloid plaques and neurofibrillary 
tangles which today are the hallmark characteristics synonymous with Alzheimer’s 
disease [22]. 
2.1 Overview and Impact 
As Alzheimer’s disease progresses in the brain, a buildup of amyloid plaques occurs 
along with a noticeable destruction of neuronal connections reflecting 
neurodegeneration. Typically, the hippocampal brain region (associated with memory) 
is the first area to have noticeable damage followed by other areas of the brain. Once 
Alzheimer’s disease has progressed to the state of being clinically detectable, there may 
be damage throughout the brain along with a reduction in overall tissue volume [24]. 
The neurodegeneration occurs over time and eventually leads to a decline in cognitive 
and functional abilities [16]. Alzheimer’s disease is known to begin years before 
symptoms are detectable. The lack of detection allows degenerative biological states to 
exist within individuals where disease pathologies can go undetected and unchecked 
for several decades before symptom presentation, such as memory loss, are seen 
[2],[3],[6],[11],[27].  
The 2020 Alzheimer’s Association Report identifies the most common causes of 
Dementia to be Alzheimer’s disease, Cerebrovascular Disease, Lewy Body Disease, 
Frontotemporal lobar degeneration, Parkinson’s Disease, and Hippocampal sclerosis. 
Mixed pathologies occur when an individual shows more than one cause of Dementia 
[16]. This study highlights the fact and figures of Alzheimer’s disease due to the high 
prevalence of disease; however, Alzheimer’s disease was not the only form of 
Dementia within the data. Dementia, in general was used for analysis. Alzheimer’s 
disease is the most notable and prevalent form of Dementia and contributes to around 
60 to 70 percent of all Dementia cases. The term Dementia describes the neurocognitive 
and functional decline of patients and is the overarching terminology used to 
characterize symptoms of memory loss along with changes in thinking, language skills, 
and problem solving. This study utilizes Alzheimer’s disease as an additional outcome 
due to the high prevalence of the disease; however, Alzheimer’s disease was not 
specifically identified within the data. Dementia, in general was therefore used for 
analysis as the primary outcome variable.  
Most concerning is the seriousness of the damage caused by Alzheimer’s disease 
and the staggering occurrence rates. As of 2017, experts have estimated 5.5 million 
Americans have Alzheimer’s disease, and the disease is not just limited to the senior 
community. The incident rates of Alzheimer’s disease continue to increase as the global 
population grows and continues to age [22]. To put these large numbers into 
perspective, 1 in 10 people age 65 and above experiences Alzheimer’s disease or some 
form of Dementia [9]. The prevalence (existing cases) of Alzheimer’s disease also 
increases with age; ranging around 3% of people aged 65−74 to 32% of people age 85 
and above [9]. Patient lifespan post diagnosis may range from 3−10 years, Alzheimer’s 
disease is estimated as the sixth leading cause of death in the United States and possibly 
the third leading cause for the older community. The only other causes of death that 
ranked higher for the elderly population was heart disease and cancer [22].  
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It is estimated that more than 16 million unpaid caregivers provide care for 
individuals with Alzheimer’s disease and Dementia. These unpaid caregivers provided 
an estimated 18.6 billion hours of unpaid care, valued at $244 billion dollars in 
contributions in 2016 [16]. Caring for a person with Alzheimer’s disease has special 
challenges and levels of care will likely increase with the progression of the disease. 
As the disease worsens, more serious health problems usually arise. Incomes and 
finances regularly become depleted causing high levels of emotional stress and 
depression for many of these caregivers [16]. Direct care (paid) workers, usually 
nursing assistants, consistently have a difficult job due to a lack of training and 
education required for Alzheimer’s disease and Dementia care.  
Making matters worse, as of 2016, there is a shortage of certified geriatricians with 
only 7,293 in the United States. That is one geriatrician for every 1,924 Americans age 
65 or older in need of care [16]. The American Geriatrics Society estimates that by 
2030 an additional 23,750 geriatricians are needed to meet the aging population [16]. 
In 2017, Medicare started reimbursing healthcare professionals for comprehensive 
Dementia health care plans for care visits to help address short comings in healthcare 
planning. Medicare stated prehensive care planning is a core element of effective 
Dementia care management and can result in the delivery of services that potentially 
enhance quality of life for people with Dementia and their caregivers [16]. 
The economic impact and cost have enormous implications for individuals and their 
families affected by Alzheimer’s disease. Lifetime costs for care of a single individual 
were estimated at $357,297 in 2019 [14]. Alzheimer’s disease and Dementia have 
become the costliest condition, with over $290 billion made in payments 2020 for 
health and long−term care [10]. Considering the population of individuals currently 
with Alzheimer’s disease today (5.8 million) and the number of individuals forecasted 
in future (88 million affected by 2050), the estimated cost is projected to reach $4.6 
trillion. The estimated number of future cases, high costs of care and ageing population 
push the importance of an early diagnostic test to a real priory for public healthcare. 
   
 
Figure 1: Aggregated costs of healthcare payments made by Americans age 65 and 
older with Alzheimer’s disease or dementia in 2020. Reported in the Alzheimer's 
Association Report and data displayed from the Lewin Model [22]. 
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Despite the dire consequences of developing Dementia or Alzheimer’s disease, there 
is currently no cure, and there is still much to learn about the disease itself. There are 
currently only 5 FDA approved medications, none of which has shown supportable 
evidence for the permanent reduction/remission of Alzheimer’s disease symptoms. 
Rather, the only limited achievements of these medications are to manage and slow the 
symptoms of neurocognitive degradation characterized by Alzheimer’s disease and 
Dementia. To say medication development has been slow would be an understatement, 
as there are no medications that prevent or delay the progression of the disease. The 
most recently FDA approved Alzheimer’s disease medication is simply a cocktail of 
two other Alzheimer’s disease drugs from 23 and 16 years ago. There are efforts to 
develop new medications. However, clinical trials have seen a staggering 99.6% failure 
rate. 
Many research documents cite major challenges in that there is still not much known 
about the cause of Alzheimer’s disease and that finding Alzheimer’s disease patients at 
early development stages is crucial. It has been estimated that potentially half of 
patients with Alzheimer’s disease are undiagnosed or experience anosognosia (inability 
to recognize they have memory changes) [16],[11]. Not having access to effective 
screening solutions perpetuates missed diagnoses. A rule out screening method that can 
effectively identify most of the population without the presence of Alzheimer’s disease 
or Dementia allows the focus to shift towards those at-risk patients. Finding suitable 
clinical trial participants has been difficult and has high costs associated with it. 
Without a suitable pool of subjects, it becomes extremely difficult to carry out research 
on Dementia and Alzheimer’s disease. The rule out screening method is a novel way to 
overcome some clinical trial hurdles by lowering the cost of inclusion and exclusion 
criteria for trials ensuring the focus and expense is used on individuals who can help 
drive development of potential lifesaving measures, treatments, and medications [1].  
2.2 Detection Approaches and Related Works 
The gold standard screening methods used to identify Dementia and Alzheimer’s 
disease are Positron Emission Tomography (PET) and CSF marker analysis, each have 
their own respective tradeoffs. To date, there have not been any predictive models 
approved by the FDA, which creates a gap in screening. Gold standard methods are 
expensive and may not be covered all by insurance providers. In recent years, research 
advancements of noninvasive screening methods have been developed utilizing 
predictive analytics.  
The major advantage in utilizing Machine Learning methods is that screening can 
be done on larger populations and at-risk individuals can be identified in a low-cost, 
noninvasive manner. Therefore, using predictive analytics to identify undiagnosed 
Alzheimer’s disease and Dementia can provide real value to the realm of research and 
treatment by way of earlier diagnosis. Although the field of predictive analytics has 
been around for quite some time, recent advancements in computing capabilities and 
research in the field have led to much more widespread adoption in the industry. 
Predictive Analytics and coined terms such as “Machine Learning” and “artificial 
intelligence,” consists of preparing, cleaning, and processing suitable training data in 
5
Stephan et al.: Rule out Screening for Undiagnosed Dementia and Alzheimer’s Disease
Published by SMU Scholar, 2021
order to train a series of predictive mathematical models. From there, the models will 
typically “learn” by calculating a loss function to measure the total accuracy (or other 
chosen performance metric) of the model and then back propagation seeks to adjust 
model weights in order minimize aforenoted loss function.  
Several groups have demonstrated success using Machine Learning and predictive 
analytics. McCoy et al (2018, 2019) aimed to help prevent Dementia by identifying 
pre-symptomatic and/or individuals with minimal symptoms that were at high-risk for 
Dementia. McCoy and colleagues identified that traditional current detection of 
Alzheimer’s disease and Dementia are expensive, and that reliability and scalability are 
not consistent. McCoy subsequently proposed that an Electronic Health Record (EHR) 
method of screening could be a potential solution for early detection [18]. In their work, 
Natural Language Processing (NLP) was used on free text from hospital discharge notes 
where a "Cognition Score" was generated and compared with other medical records. 
These discharge notes capture key indicators of Alzheimer’s disease that may not be 
captured by ICD−10 codes. ICD-10 codes are a standardized set of codes that classify 
and document disease diagnoses. For analysis, each study site data was merged to form 
a holistic view [17]. Association between model score and Alzheimer’s disease related 
death rates were then studied to better understand the progression of Alzheimer’s 
disease. The McCoy paper further states additional validation is needed to show the 
effectiveness of the NLP approach and the need for future iterations of the model to 
incorporate other biomarkers and medical records. From McCoy’s work, a lexicon 
containing Alzheimer’s disease and Dementia key words and stop words has been made 
available. Incorporating the limitations mentioned by McCoy, use of additional fields 
and NLP analysis may build a more robust and predictive model.  
The Scripps Research Translational Institute utilized over 1 million patient medical 
records representing 11 years of data. The incidence of Alzheimer’s disease was low in 
the study population. To allow the models to better classify the low volume of 
Alzheimer’s records, the data was balanced using bootstrap sampling. Random Forest, 
Support Vector Machine, and Logistic Regression were utilized on 5 groups of data 
with time points zero, one, two, three, and four subsequent years incidence of 
Alzheimer’s disease. Within each group the models classified Alzheimer’s records with 
the following operational definitions: definite Alzheimer’s disease and probable 
Alzheimer’s disease based on patient medical records. The top 20 features were 
selected using Logistic Regression, then used in other models for comparison. Several 
key features that were identified were elevated urine protein, Zotepine, and several 
ICD-10 codes. These features were deemed statistically significant and produced high 
odds ratios for Alzheimer’s disease suggesting that these features were more strongly 
associated with incidence of disease. 
The Scripps group showed Random Forest models had the highest accuracies for 
most of the subsequent years of incidence for definite and probable Alzheimer’s 
disease. Predictions are acceptable for 0−and 1−year incidence with an AUC of 0.898 
and 0.775 respectively [18]. However, as time increases to 4 years the model 
performance starts to decrease. This trend was consistent across all models for 
prediction of definite or probable Alzheimer’s disease. This research does not mention 
the use of any free form text field or the use of Natural Language Processing techniques 
to model this data. Relevant information captured from a doctor’s observations could 
provide key indications for Alzheimer’s disease incidence.  
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Another interesting point presented by the Park et al paper described feature 
selection using a Logistic Regression approach for comparison with other models. 
Several key risk factors were identified and have shown to contribute to Alzheimer’s 
through their high odds ratios; this can be used as a potential starting point for our 
group’s models [23]. 
The papers from the Center for Quantitative Health at Massachusetts General 
Hospital, Harvard, and Scripps Research Translational Institute both suggest that 
document classification can be used to improve the efficiency and increase robustness 
of predictive models. The paper by Peng et al shows how document classification 
accuracy can be improved over traditional "bag−of−words" using Natural Language 
Processing techniques to extract word senses and from the context of the entire 
document. This approach provides a potential 14% increase in accuracy over 
bag−of−words techniques [24]. Peng suggests a shift in modeling from word 
frequencies to sense frequencies. Senses rely on the meaning of words and the 
relationships between groups of meanings [24]. 
Shifting from a lexical to a semantic approach allows for a better understanding of 
how words are related in the context of their meanings. There are situations where the 
same word is used but has different meanings. A quarter can mean an American coin, 
twenty−five percent, or a football formation. Peng’s research in semantic analysis 
suggests gains in accuracy over lexical techniques and offers a high−level approach to 
handle documents to help generate better accuracy. These techniques can be used on 
doctor notes contained in EHR to help understand the relationship between comments 
captured in the notes. 
In lexical analysis this information is not utilized, and the frequency of a word is 
measured. However, in semantic analysis the meaning of the word is utilized and is 
dependent on the context of the words surrounding it as seen in Figure 2. 
 
Figure 2: Example of semantic similarity of words in context. (target orange, context 
blue) 
To represent a document, a hierarchy of word senses is first constructed. Words are 
then mapped to synsets, groupings of words with similar meaning, which are then 
labeled with a word that captured the meaning of their relationship. Following this, the 
relationships are captured, and documents are then compared to predefined categories 
with each synset document representation. Documents with the closest similarities to 
the category were then grouped with that particular category [24]. Peng et al mention 
that the methods studied were limited by the lexicon utilized. Language is constantly 
growing and evolving. If a lexicon is not updated, lexical or semantic approaches may 
not be sufficient to cluster future documents as new words and their meanings may not 
be captured. This argument is held for any NLP project as most projects rely on current 
lexicons. 
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2.3 Combining Approaches 
For research that utilized NLP, authors mentioned incorporating other biomarkers or 
features that were contained in other medical records to build more robust models. 
Conversely, in papers that utilized continuous or categorical features, researchers often 
mentioned incorporating free form text into their models to increase model 
performance. In either case, free form text in EHRs contained in doctor notes could 
contain insights related to symptoms associated with Alzheimer’s disease or Dementia, 
and biomarkers and other health records may contain attributes characteristic of 
Alzheimer’s disease or Dementia. This research aims to improve upon the limitations 
mentioned in the previous research by incorporating both free form text from doctor 
notes in EHR records or other biomarkers and continuous data a patient may have. 
3   Methods 
This research makes use of several Machine Learning algorithms which were chosen 
due to their widespread acceptance in medical industry and transparency compared to 
more complex approaches, such as neural networks. Considering the need for ease of 
interpretation by the doctors and medical staff, several models meeting this criterion 
were evaluated on EHR medical records. Given the prevalence of Alzheimer’s and 
Dementia are low, negative predictive value was deemed the best metric to judge model 
performance. Negative predictive value and positive predictive value statistics are 
regularly used to describe the performance of diagnostic tests. Negative predictive 
value also considers the prevalence of the disease and therefore considers what percent 
of the time the test correctly detects no disease. It does so by comparing the total number 
of true negative to all negative predictions (true and false). The Negative Predictive 
value was used to measure model performance for those individuals who do not have 
Alzheimer’s or Dementia  
3.1 Logistic Regression 
Logistic Regression is a classification algorithm commonly used in current detection 
approaches which may be used to solve single or multiple variable classification 
problems. Logistic Regression improves upon multiple linear regression (MLR) for 
categorical predictors by forcing all predictions to have values between 0 and 1, 
mitigating ordinal effects of multiple categories which may occur in a quantitative 
algorithm such as MLR [12]. This study will utilize multiple classifications with 
Logistic Regression and one-hot encoding, assigning a new feature representing a 
condition in the binary states of the condition is present or the condition is not present. 
The Logistic Regression models will assign coefficient weights to each feature and its 
effect on the outcome probability. 
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Figure 3: Example of classification using Logistic Regression. 
This paper will utilize models making use of the log−odds ratio as it relates to the 
response, which may be interpreted as: adding one unit to X changes the log odds of 
the response by β1 or multiplying the odds by eβ1 [25]. This gives us the ability to 
interpret models using log odds. Ramsey and Schafer provide a practical example of 
interpreting log odds: 
For example, it is possible with retrospective samples of lung cancer patients 
and of patients with no lung cancer to make a statement such as: The odds of 
lung cancer are estimated to increase by a factor of 1.1 for each year that a 
person has smoked. This result has tremendous bearing on medical case–
control studies and the field of epidemiology. (p. 609) [25].  
Logistic Regression carries assumptions similar to MLR, in that high leverage outliers 
can severely impact prediction results, and the assumption is that residuals have equal 
mean and variance across the X predictors. These assumptions are checked and can be 
validated in the notebooks containing the code for this research paper. 
3.2 Random Forest 
Random Forest models will be used to benchmark model quality and will act as the 
baseline for comparison to other models and applicable research in other papers due to 
its ease of implementation and highly explainable nature. The model itself is comprised 
of an ensemble of decision trees which can either yield a continuous or categorical 
response [29]. These decision trees are often referred to as Classification and 
Regression Trees (CART) algorithms [7].  
The anatomy of a decision tree consists of a series of decision nodes that split into 
branches/edges. Navigation down the decision tree continues through each node and 
down the branches until there are no more splits at which case a response, continuous or 
categorical, is the final step [28]. The manner in which a decision tree does this is based 
on the training features and conditions required for splitting each decision node. As a 
result of a technique coined recursive binary splitting, all provided features are 
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For classification-based decision trees, a common cost function is the Gini score, 
which calculates a measure of the homogeneity of the response classes in each group of 
a potential split [7]. In the formula provided below, pk is the proportion of homogeneous 
response in a group. An ideal split will produce a pk value of 1 or 0, but a 0.5 for the worst 
fit on a binary classification problem [7]. 
 
Classification: G = sum(pk * (1 — pk)) 
 
Due to the greedy, recursive nature of the algorithm to excessively minimize the cost 
function, a large number of splits may be present that could make model interpretation 
difficult and result in an overfitted model [7]. Decision trees can have exceptional 
performance on training data and are often quite easy to explain, but often under-
perform in real-life scenarios due to their tendency to overfit the training data. In order 
to achieve a more useable model, various adjustments and techniques can be employed 
to increase model predictability and robustness. 
One such possibility utilized in this research is an ensemble (or collection) of 
uncorrelated decision trees, often referred to as a Random Forest (aforementioned). For 
classification tasks, the Random Forest will have each decision tree create a prediction 
of a response and the response with the most votes is the ensemble output [29]. In 
essence, the ensemble model allows for the errors of an individual decision tree to be 
reduced or masked by the other trees in the ensemble [29]. By using the “public 
opinion” of the collection of the models as a whole, in contrast to that of a specific 
model, the ensemble method is much more robust against model overfitting and often 
leads to a higher model performance in real world applications [29].  
 
 
Figure 4: Example of an ensemble of decision trees created by a Random Forest 
classifier. 
AdaBoost was also utilized and is similar to Random Forest in that it combines 
multiple weak learners to generate a strong learner. Weak learners don’t generalize well 
to new data because they are overfit or have poor accuracy, but when many weak 
learners are combined, they generate a good, generalized representation of the data. 
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3.3 Support Vector Machine 
Support Vector Machines (SVM) are a type of Machine Learning algorithm that can be 
used for both regression and classification. Although it can work in a regression 
problem, it is much more commonly employed in classification problems that utilize 
the creation of hyperplanes to differentiate between classes. Observations that are 
present on either side of the hyperplane are associated with a class.  
 
 
Figure 5: Example of a classification problem using Support Vector Machine. 
The creation of the hyperplane is typically of n-1 dimensions where n is the number 
of dimensions present in the data [4]. For example, if a collection of observations with 
3 features (excluding response) are trained with the algorithm, the hyperplane that splits 
the classes will be 2 dimensional [4]. Due to the infinite nature of a hyperplane, it is 
often more practical to describe the hyperplane as a sequence of vectors, often referred 
to as support vectors [4]. To improve model performance, the algorithm utilizes a hinge 
loss function to maximize the distance between the support vectors that achieves the 
greatest separation of classes [4]. 
 In SVM, outputs are normalized to a range of -1 and 1 upon which margins of the 
support vectors run [4]. The cost function of the SVM yields a value of 0 if the 
prediction and actual values have the same sign, whereas opposite signs yield a 
measurable loss value [4]. The cost function will seek to maximize the margin of 
separation between each class and subsequently minimize loss [4].  
In simpler terms, SVM is designed to maximize the distance between each class 
separating hyperplane, and the nearest points to it, also known as the support vectors. 
This distance is called the margin, and SVM attempts to draw the optimal line through 
the observed data that provides the most margin for all support vectors. This line is not 
always 100% linearly separable, so we can incorporate slack variables, which allow for 
observations to be on the wrong side of the hyperplane [8]. These slack variables are 
used in conjunction with residuals in the cost function to penalize large residuals by a 
user defined, constant C amount [15]. This constant C is one of the primary parameters 
of SVM that by changing, may result in better classification results as it adjusts the 




Stephan et al.: Rule out Screening for Undiagnosed Dementia and Alzheimer’s Disease
Published by SMU Scholar, 2021
3.4 Natural Language Processing 
Natural Language Processing (NLP) is a process that allows for analysis of text data at 
scale and is the use of machine-based methods to process natural language – an example 
of this would be the use of NLP on doctor’s notes from EHR. NLP consists of two main 
sub-categories of language processing: Natural Language Understanding (NLU) and 
Natural Language Generation (NLG) each comprised of subcategories that serve 
similar but different purposes, utilize different techniques, and generate different 
outputs. 
NLU is a process used to create a useful representation of ingested natural language 
that is understandable to a machine. This requires the use of artificial languages, such 
as python, R, Java, etc. to provide instructions to a machine on how to cluster, classify, 
tag, and query text. NLG is the transformation of structured data into human 
comprehensible words, phrases, or sentences. Common application of this form of 
language processing includes text summarization, labeling of clusters, and question 
answering.  
Text data was prepared on the lexical level to allow for unsupervised clustering of 
EHR features into groups that were most similar to each other. Term frequency (TF) 
and term frequency inverse document frequency (TF-IDF) values were used with k-
means clustering, and TF and trigrams with Latent Dirichlet Allocation (LDA) for topic 
modeling. The clusters were captured as engineered features for utilization by Random 
Forest, Logistic Regression, or SVM model that contains other risk factors and features 
associated with a patient record like age, BMI, medical tests taken, and ICD-10 codes 
as seen in Table 1.  
Table 1: Example of Electronic Health Record schema with NLP-engineered feature. 
Patient 
Number 
Gender BMI ICD-10 Physician Comments NLP-Engineered 
Feature – At-risk 
for Alzheimer’s 
12345 F 22 F63.0 Patient described risky behavior 
when gambling 
0 
67891 M 26 F20 Patient described memory issues 
and difficulty speaking  
1 
01112 F 25 F03 Patient mentioned forgetfulness 1 
3.5 Model Training and Hyperparameter Training 
Data for modeling was partitioned into a train and test sets, where 70% of the data was 
used for training and 30% was used for testing. The national prevalence rate reported 
for Alzheimer’s disease is only 10 percent. Since the number of records containing 
Alzheimer’s disease or Dementia were infrequent it was important to up-sample these 
the training set to improve model performance. This was done using Synthetic Minority 
Oversample Technique (SMOTE), where synthetic records containing minority class 
attributes are generated. Up-sampling is performed when there is a class imbalance in 
the response. This is done because it can be difficult for a model to effectively classify 
when there is a class imbalance. If a model is run on data that is imbalanced 
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performance metrics typically would underperform. The data set generated by SMOTE 
was then used in the grid search cross validation process during the training phase.  
To maximize model performance an exhaustive grid search and cross validation was 
performed. Parameters for each model were selected and a range of values within each 
parameter were assigned to a parameter grid. The up-sampled training data was then 
loaded into a 3-fold cross-validation object. During the grid search, all permutations of 
the parameters were generated then trained on one portion of a fold and tested on the 
remaining portion. This process is repeated until all fold permutations are trained and 
tested. Once this process is complete, the grid search is able to identify which 
permutation of parameters for a particular model performs best in terms of a user 
specified metrics. 
4   Data Description 
The Electronic Health Records utilized for this research were obtained from the 
University of North Texas Health Science Center (UNT HSC) in Fort Worth. The data 
is a convenience sample from 3 different clinical settings: Geriatrics, Family Medicine 
and Seminary Medicine consisting of EHR for patients 65 years and older. The dataset 
spans from January 2016 to December 2019 and contains 4,995 unique patients totaling 
46,690 patient visits. There were 3,950 normal patients, 516 Alzheimer’s disease 
patients and 889 Dementia (Alzheimer’s disease and others) patients. The total number 
of patients that are diagnosed with Alzheimer’s disease or Dementia as a proportion of 
the total is at 17.79%. The total proportion of patients with Alzheimer’s disease is 
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Table 2: All tables were relationally linked by Encounter_ID and Person_ID. 
Table Definition 
Encounters Data related to a patient visit where a patient could 
have multiple visits. 
 








Related ICD-10 and doctors' free-from assessment 
detailing the visit.  
 
Data related to a patient’s ordered laboratory tests and 
corresponding results. 
 
Medications Data related to patient’s prescribed drug(s), dose, 
current or not current. 
 
CPT_codes Codes related to patient’s tests, surgeries, evaluations 
for billing and the patient’s free-from reason for visit.  
ICD-10 Codes related to patient’s diagnosis recorded as codes. 
4.1   Data Preparation 
To adequately utilize all the data available, the tables containing the EHR data outlined 
in Table 2 were joined using the unique encounter id that linked all the tables together 
in a relational manner. There was a one-to-many relationship between the unique 
patient id and the encounter id, meaning that it is possible for multiple iterations of a 
single patient’s information to be present in the dataset. The central table onto which 
we planned to join all of the other tables was the “Encounters” table, which houses all 
patients and visit metadata. Some fields from this table were gender, age, reason for 
visit, and more. After dropping columns that lack diagnostic properties (insurance 
provider, location, etc.), from the encounters table we then moved onto merging the 
other tables using the unique encounter id as the main key. 
The vitals table is comprised of commonly taken information from when the patients 
entered the facility such as temperature, weight, height, body mass index, and blood 
pressure. It was possible for patients to have multiple vital measurements taken within 
a single visit. When multiple measurements occurred, we took the median of the 
continuous vital measurements to “flatten” the vitals to a one-one relationship between 
the unique encounter and the vital information. After this process was completed, the 
vitals table was joined onto the encounters table.  
The assessments table contains the doctor’s “free form” notes about the patient. This 
table is a unique perspective that the study offers because the opportunity to leverage 
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the text data can allow for relationships that humans understand, but previous research 
has not used because much of its content is not necessarily measurable and tends to be 
more subjective in nature. In order for Machine Learning models to ingest unstructured 
text data, the “bag of words” must be transformed into a matrix of continuous features. 
To achieve this, all words were stemmed and converted to lowercase. Following, “stop 
words”, words that do not add to the context of a physician note such as: “a”, “and”, 
“the”, “he”,” she” and other articles and pronouns were removed. Next, the remaining 
nouns and verbs after stop word removal were then put into a Term Frequency – Inverse 
Document Frequency (TF-IDF) which created a dense matrix of continuous 
representations for each unique word remaining in the corpus. Due to the excessive size 
of this table, the dense matrix was used to create engineered features by utilization of 
k-means clustering. The clusters created logical, separate bins to group various text 
fields to a higher-level summary in a much more dynamic way. Once the clusters were 
created, each text derived feature was one-hot encoded to generate a sparse, yet reduced 
representation of the original matrix. The resultant structure was joined back onto the 
original encounters table for use in modeling.  
In addition to k-means clustering, Latent Derelict Allocation topic modeling for 
physician notes in the assessments table was also performed. Data was cleaned using 
the same aforementioned process as the k-means clustering. Tokens were then formed 
into trigrams, or, three-word chunks, to identify the most common three-word topics. 
The trigrams were then loaded into a Term Frequency (TF) matrix. Once the topics 
were generated, each record in the assessments table was labeled with its corresponding 
topic, then encoded, and joined to the encounters table using the unique encounter ID. 
The labs table contains patient lab information, according to the tests ordered by the 
patient’s physician. The lab information constitutes a variety of features that required 
different forms of feature engineering to tidy data in a format that would work well 
with a Machine Learning model. When concentration ranges were given, the median of 
that range was used; if a maximum or minimum range was given, the high or low cut-
score was used. Besides continuous lab results, some labs contain information of a more 
categorical nature. Among these are results of “normal” or “abnormal”. Utilizing these 
specific labs required one-hot encoding of the potential values available for that lab. 
The continuous types of lab result were found to have much less feature importance 
than the abnormal lab work ind. Many of the labs with a categorical response were 
observed to have non-significant feature importance and were not utilized in the final 
dataset. After reduction all labs were joined onto the encounters table.  
The medication table is comprised of the entire medication history for each unique 
patient. In order to ensure data leaks are not present, medications needed to be filtered 
using the dates provided in both the medication table and the encounters table. This 
ensured that only current medications up until the encounter were used in the final table. 
Once the “current” medications for that individual patient and encounter were subset, 
the output was joined onto the encounters table using encounter id.  
The CPT codes table is comprised of various procedures performed during the 
patients’ visit for billing purposes. It was suggested that use of the procedures in the 
dataset may help determine if other ailments could be used for screening purposes. 
Several diseases (diabetes, hypertension, depression) are known comorbidities and 
occur more frequently for individuals with neurocognitive disease. The CPT 
description was joined back onto the encounters table using the encounter id.  
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The ICD-10 table is comprised of documented diagnoses for a patient. In all, there 
were 4,753 unique ICD-10 codes with the data set. This caused excessive addition of 
features when one-hot encoding. To reduce feature space, we used lower granularity 
representation of the ICD-10 code by mapping to a Clinical Classifications Software 
Refined (CCSR) code which reduced the dimensionality of ICD codes from 4,753 to 
just 415 unique codes [26]. To prevent target leakage, records containing the NVS011 
CCSR code, a group of 25 ICD-10 codes specific to neurodegenerative diseases, were 
removed. Once the feature reduction was complete, the ICD-10 table was joined back 
onto the encounters table.  
4.2   Exploratory Data Analysis 
Exploratory Data Analysis (EDA) has identified trends showing strong correlation in 
several features. Age is the number one factor, and greatly increases the likelihood of 
dementia. The median age for those diagnosed with neurocognitive disorders is almost 
10 years older than those without the diagnosis.  
 
 
Figure 6: Correlation matrix of Age, Weight, BMI, height, pulse, and neurocognitive 
disorder. 
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Figure 7: Correlation matrix of systolic and diastolic blood pressure, assessment topic 
8, temperature (F), diagnosis of nervous system signs and symptoms, and 
neurocognitive disorders. 
 
Figure 8: Correlation matrix of respiration rate, assessment group 13, diagnosis of 
depression, reason for visit group 2, and neurocognitive disorder. 
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Figure 9: Visualization of age distribution for Alzheimer’s disease and Dementia 
patients. 
 
Figure 9: Visualization of median age differences between patients with/without 
Alzheimer’s disease and Dementia patients. 
 
 
Figure 10: Visualization of median weight distribution for Alzheimer’s disease and 
Dementia patients. 
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Figure 11: Visualization of weight vs age by gender for each patient type 
The median age for those diagnosed with neurocognitive disorders is almost 10 years 
older than those without the diagnosis. 
 
 
Research also shows that Alzheimer’s disease and Dementia patients are typically 
underweight compared to their healthy peers. Figures 10-12 display compelling 
evidence that weight could be a factor in predicting neurocognitive disorders. 
Alzheimer’s disease and Dementia patients have a higher percentage of depression 
than healthy peers in the sample population. Figure 14 exemplifies our finding support 
research by Johnson et al [13].   
Features identified from EDA turned out to be influential within each Machine 
Learning algorithm. Random Forest and Logistic Regression reported weights strongly 
associated with each of these features as shown in the results section. 
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Figure 13: Visualization of age distribution for Alzheimer’s disease and Dementia  
patients. 
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Figure 14: Visualization of the effect of depression on each patient type. The features 
identified in this EDA turned out to be influential features within each Machine 
Learning algorithm. Random Forest and Logistic Regression reported weights 
strongly associated with each of these features as shown in the results section. 
5   Results 
To build the initial model encompassing all years, the entire dataset was used in a 3-
fold cross validation using stratified splits to maintain target ratios. Initial model 
building started with a stepwise selection approach using all 1,296 predictors available 
in the data set. All features were investigated and scrubbed of any information that 
could leak the response variable Alzheimer’s disease or Dementia such as NVS011 
CSSR codes and text fields that had direct indication or mention of the disease. Text 
features were reviewed for response variable before and after NLP processing. After 
obtaining coefficients for all features, feature reduction was applied, narrowing down 
coefficients to a smaller subset of 150 of the features with highest correlation to reduce 
overfitting and model complexity.  
Multiple sets of data were created from patient encounters by grouping patients into 
their first year, second year, third year, fourth year and beyond visits, and all encounter 
occurrences. The intent of sub-setting by annual visit number allows for clinicians to 
stratify patients into the most logical bin for rule out of Alzheimer’s disease or 
Dementia. Additionally, inclusion of an all-data superset allows for model comparison 
against yearly data.  Each year’s subset was then split into a 70/30 set in which the 
training set was up-sampled to improve model performance by ensuring the model is 
not biased towards the most common occurrence (individuals without Alzheimer’s 
disease or Dementia). Each model for each training set was fitted using cross validation, 
and features were manually reduced using highly correlated medication and CPT code 
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data resulting in 661 total features. The best model fit resulting from the cross validation 
was then measured using the hold out set. 
After performing an exhaustive grid search on Logistic Regression, Random Forest, 
and SVM, the best models for their respective subset are listed in Table 3. 
Table 3: Best model type by year and best model for all data. 













NPV 0.9798 0.9741 0.9891 0.9635 0.9886 
ACCURACY 0.8424 0.8352 0.8710 0.8754 0.9081 
SPECIFICITY 0.8511 0.8480 0.8759 0.8997 0.9167 
SENSITIVITY 0.2060 0.1948 0.1828 0.3071 0.1235 
AUC 0.5929 0.5845 0.5860 0.6352 0.5560 
 
The best performing model was AdaBoost on all data. It returned the highest 
negative predictive value, accuracy, and specificity for all models and all years. The 
next highest performing model was the year 3 Random Forest model, followed by the 
year 1 Random Forest model. All models in Table 3 show strong negative predictive 
value, accuracy, and specificity but are not as strong in sensitivity or AUC metrics. 
Negative predictive values and specificity are metrics that identify a model’s ability 
to correctly detect negative values. Negative predictive value (NPV) is a ratio between 
true negatives and true negatives plus false negatives, while specificity is a ratio of true 
negatives over true negatives plus false positives. Since the test set is representative of 
the whole dataset, many of the records are negative for Alzheimer’s disease or 
Dementia. The models for each year show an exceptional ability to detect true negatives 
in the data. 
Sensitivity is the ability for a model to detect true positives for all classified positive 
cases. All models performed poorly in this area as the scores were not able to surpass 
0.2060. The sensitivity scores were low due to preferential fitting towards the highest 
NPV possible in order to reduce unnecessary testing.  
Correctly framing the “context of use” for the rule out screening is critical for 
determining success. Models investigated here have an exceptional ability to screen 
patients and identify those who does not have Alzheimer’s disease or Dementia with 
an NPV between 97.78 and 96.35% over a 4-year time span. The median number of 
doctor visits for all patients during this time span was 6-7 visits; indicating the rule out 
screen would likely have been able to screen all patients 65 years and older, who saw 
their doctor.   
Sensitivity and specificity metrics are usually associated with gold standard tests 
(CSF and PET). Performance characteristics for rule out screening, such as NPV and 
PPV, are used to determine how well predictions were made considering prevalence. 
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The rule out screening demonstrated very accurate detection rate of 75% for individuals 
that truly do not have disease (NPV ≈ 98.86% overall). Unfortunately, after accounting 
for the prevalence rate, the rule out screen has a high false positive rate and does not 
reliably identify Dementia and Alzheimer’s disease in the overall population. Rule out 
screening only correctly identified ≈ 15% of patients with Dementia and Alzheimer’s 
disease (PPV ≈ 18 %). Future comparison of rule out screening to gold standards tests 
would help to support findings from this study.  
Natural Language Processing generated several clusters that ranked high in Random 
Forest feature importance. Out of nearly 1,200 features, 13 NLP-engineered features 
were in the top 50, and 3 were in the top 15. The use of NLP features with traditional 
Machine Learning techniques has been infrequently mentioned in previous research 
and shows promising results as they contribute to models in a significant manner. 
Accuracy scores for all models had values ranging from 0.8352 to 0.9081. Accuracy 
is a ratio of true positives and true negatives over the total samples. Since negative 
values account for over 85% of the data much of the accuracy score is due to each 
model’s strong ability to detect negative cases. However, each model’s poor 
performance in detecting positive cases prevents the accuracy score from being stronger 
and closer to the model NPV. 
AUC also performed poorly for all models as AUC scores depend on a balance of 
specificity and sensitivity scores. Due to each model’s poor performance in sensitivity, 
the resulting AUC scores are also low. 
Table 4: Random Forest Feature Importance for All Data Model – Top 15 Features. 
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Random Forest can also be used to determine features that contribute most to model, 
or feature importance, using Gini Importance measures in which more important 
features have larger values and less important values have smaller values. Gini 
importance is calculated by adding decreases in node impurity and averaging the 
differences for all trees. Using these values, the top n features can be subset and used 
to trim insignificant features from the model in order to avoid overfitting. Feature 
importance for both future modeling and model understanding was derived by fitting 
the best performing Random Forest model on the whole data set. Once the model was 
fit, the feature importance attribute was applied to the Random Forest object, where a 
data frame was generated and sorted. 
The NLP features took 11 out of the top 25 most important features using Recursive 
Feature Elimination with the Random Forest algorithm, indicating the data within 
doctors’ assessments is useful in detecting the disease. Several noticeable features 
identified as significant by Random Forest feature importance were NLP-engineered 
features: asmt_topic_8, asmt_kmeans_13, and rfv_cluster_2. Physician notes were used 
to generate asmt_topic_8 and asmt_kmeans_13 and patient’s reported reason for visit 
was used for topic rfv_cluster_2. The NLP features were named based upon the table 
they originated from and the topic or k-means cluster they were placed in, respectively.  
 
Figure 15: Visualization of word frequency within asmt_kmeans_13 cluster Larger 
text indicates more frequency. 
Rfv_cluster_2 included primarily follow-up appointment visits, consisting of 
numeric week follow-up frequencies, physical therapy appointments, and prescription 
refill timelines among other reasons. The top NLP-engineered feature, asmi_topic_8, 
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Table 5: asmt_topic_8 – LDA derived tri-gram phrases provide insight on the contents 
of this topic. 















The topics provided by this cluster, along with the asmt_kmeans_13 cluster, show 
trigrams that are strongly associated with Alzheimer’s disease and Dementia as co-
morbidities. The direct mention of diabetes mellitus, diabetes, low blood sugar, or drugs 
like metformin used to treat diabetes were important in generating the NLP feature. 
Additionally, hypertension was mentioned in this cluster demonstrating a strong 
association between the contents of this cluster, and Alzheimer’s disease and Dementia. 
6   Ethics 
Three ethical areas were identified and were required to be maintained throughout the 
course of study. 
The first ethical standard was regulation of data storage and controlled access to 
Patient Health Information (PHI). Access to the EHR records required approval from 
the UNT HSC IRB - Project Title#: 1660705-1, Reference#: 2020-11 and compliance 
to the Healthcare Insurance Portability and Accountability Act (HIPAA) required all 
EHR records were scrubbed of PHI and anonymized to prevent identification of 
patients. User access was provided by UNT HSC IT (Information and Technology) 
security, VPNs and unique login credentials to a private server were issued. The secure 
private server ensured ethical handling and storage of the data and provided an ideal 
location for cleaning, manipulating, modeling, and visualizing data and results within 
the UNT HSC domain.  
The second ethical standard was related to the Machine Learning process. The use 
of powerful computers and large data sets combined with algorithms can solve complex 
problems not directly visible to humans. This research has shown promise in utilizing 
opportunities previously untapped. The ethical conflicts that arise from Machine 
Learning algorithms are lack of transparency, reproducibility, ethics, and effectiveness. 
The article “Machine Learning and artificial intelligence research for patient benefit: 
20 critical questions on transparency, replicability, ethics, and effectiveness” was used 
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as framework of questions that were directly investigated during the creation of the 
Alzheimer’s disease and Dementia rule out screening [19]. Throughout this study the 
following 6 topics were repeatedly considered and evaluated: Inception, Study, 
Statistical methods, Reproducibility, Impact evaluation, Implementation. 
The third ethical standard was related to the current lack of predictive screening 
creating a situation where patients go unscreened or diagnosed until it is too late. The 
Alzheimer’s disease and Dementia rule out screen reports metrics showing real benefit 
could be provided to patients 65 and older when implemented. Ethically, it is in the best 
interest of public health to continue this research further defining limitations and 
implications. Some statistical concerns surrounding low PPV, false negatives and false 
positives are present. Test results need to be clearly explained to patients and doctors, 
so the correct interpretations are easily understood. The rule out screen only indicates 
no disease is present. Ethically, the interpretation of the Alzheimer’s disease and 
Dementia rule out screen can be simply stated as: the rule out screen can only detect 
absence of disease; for all other findings, patients are recommended to seek additional 
medical care and possible escalation to CSF or PET screening. 
7   Discussion 
Rule out screening quickly provides patients with information about their 
neurocognitive health. This is vastly different than current assessment practices where 
no predictive information is available. This new paradigm allows for patients to act 
based on information provided from the rule out screen. 
Gold standard screening methods historically fall short when a patient or family 
member has memory concerns. If they are interested in diagnosis/treatment, there few 
alternatives. Screening currently consists of non-predictive options and typically costs 
between one thousand and several thousand dollars. Traditional screening methods also 
suffer from a national shortage of Neuropsychologists, which may introduce several 
months delay to neurological assessments. The shortcomings of gold standard 
screenings are further exemplified when more than half of patients go undiagnosed.  
Rule out screening can be done every visit reliably, letting patients know they do not 
have any disease with very high certainty. Conversely, rule out screening cannot 
accurately confirm patients are truly positive for the disease. The test only provides 
patients that do not screen negative with the strong recommendation to consult a doctor 
for additional, higher-level testing. Multi-tiered approaches have successfully been 
used; most recently in 2020 rapid IgM/IgG testing to assess Coronavirus disease in 
emergency rooms 1-2 days before gold standard screening [30]. Breast cancer detection 
highlights the role of mammography for early-stage detection and then relies on 
biomarker and MRI when cases are escalated [31].  
This research has extended previous Machine Learning approaches that aim to 
facilitate detection and screening of Alzheimer’s disease and Dementia by utilizing 
NLP applied to doctors’ notes. There is substantial evidence that NLP has positively 
improved the prediction performance in screening for Alzheimer’s disease and 
Dementia. Identifying phrases that contribute towards feature importance score can be 
accomplished using term frequencies and word clouds. Several key phrases associated 
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with Alzheimer’s disease and Dementia like hypertension, depressive, depression, and 
disturbance are known co-morbidities. 
In addition to the NLP features, several previously discovered correlated features 
such as: age, blood pressure, under-weight, and blood sugar levels were further 
validated as significant in this research. Utilizing more complex algorithms in the NLP 
space will likely yield marginally better performance, and evidence suggests that future 
work may benefit from a deeper application of these techniques and the use of a medical 
specific lexicon. 
Despite NLP-engineered features contributing towards a large portion of model 
predictive ability improvements for detections of positive cases is needed to address 
poorly performing positive predictive power, sensitivity, and AUC. This suggests that 
more future engineering specific to positive cases needs to be done, or incorporation of 
more features used to help diagnose Alzheimer’s disease or Dementia like blood 
biomarkers, or cognitive tests should be included in future work. 
Other improvements can be made to data storage and models by migrating data to a 
graph data base. Data for this research was relational in nature and during processing 
data required aggregation of fields to flatten data to an encounter basis. In doing so a 
record was able to provide information on whether a feature occurred but was no longer 
able to provide information about the order in which features occurred within an 
encounter. Utilizing a graph database allows for these relationships to be preserved in 
a form that can be utilized by models and could be advantageous in future iterations of 
this work. Additional studies should be done that independently rule out Dementia and 
Alzheimer’s disease separately. Stratification by disease, generation of new features 
space and creation of new models which are better tuned to each disease should produce 
improved performance metrics.  
Any person over 65 or with a family with elderly members needs to consider the 
current state of healthcare: the lack of predictive tests, overly expensive gold standard 
testing that sadly ends with a terminal disease which has been historically 
underdiagnosed for years. Considering the previous statement, it only makes sense that 
rule out screening for undiagnosed Alzheimer’s disease and Dementia using an EHR 
based machine learning be considered as the first line of defense in the fight against 
these diseases. Ethically, the test does not put patients at-risk because a diagnosis is not 
given. Only the absence of disease is determined, therefore patients with a non-negative 
result would need to seek additional care for effective diagnosis. 
8   Conclusion 
The social and economic impact of Alzheimer’s disease and Dementia are incredible 
compared to heart disease or even cancer. Considering only limited treatment options 
are available for neurodegenerative disease being able to effectively use health care 
records as an early rule out tool has significant implications as well as cost-savings. 
Rule out screening described within this study uses health care systems already in place 
that more efficiently guide patient care and treatment. 
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Rule out screen has the potential to save billions of dollars for patients, healthcare, 
and insurance companies. In 2020, the Alzheimer’s Association reported staggering 
numbers for payments made by Medicare and Medicaid combined with other payments 
total nearly 300 billion dollars for the 5.8 million people age 65 and older living with 
Alzheimer’s disease and Dementia. The rule out screen as it is currently configured 
today could provide significant improvement to families and patients by providing 
knowledge where none has existed. If a gold standard testing available today screened 
everyone age 65 and older tomorrow, there would be millions of patients that would 
need to be screened. In 2020, 16.9 percent of the U.S. population were 65 and older; 
that equates to 55.9 million seniors.  Screening this entire elderly population would 
cost somewhere between 55 to 385 billion dollars depending which gold standard test 
was used. If the Alzheimer’s disease and Dementia rule out screening was used as the 
first line screening tool the number of gold standards tests could be reduced 75 percent.  
The estimate savings would be 41.2 to 288.8 billion dollars compared to only using 
gold standard screenings. The rule out screening described with this study will 
considerably reduce screening costs, increase accessibility, improve healthcare options 
for our elderly population. It is important to acknowledge that the findings of this 
research have shown great potential for use of NLP in detection of Alzheimer’s disease; 
however, more research should be performed until conclusive decisions can be made 
as to whether an individual has Alzheimer’s disease.  
 
Acknowledgments. Jacquelyn Cheun, Ph.D.1, and Faizan Javed, Ph.D.1, – Capstone 
Professor  
References 
1. Deborah E Barnes, Jing Zhou, Rod L Walker, Eric B Larson, Sei J Lee,W John Boscardin, 
Zachary A Marcum, and Sascha Dublin. Development and validation of eradar: A tool using 
ehr data to detect unrecognized dementia. Journal of the American Geriatrics Society, 
68(1):103–111, 2020. 
2. Randall J Bateman, Chengjie Xiong, Tammie LS Benzinger, Anne M Fagan, Alison Goate, 
Nick C Fox, Daniel S Marcus, Nigel J Cairns, Xianyun Xie, Tyler M Blazey, et al. Clinical 
and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med, 367:795–
804, 2012. 
3. Heiko Braak, Dietmar R Thal, Estifanos Ghebremedhin, and Kelly Del Tredici. Stages of the 
pathologic process in Alzheimer disease: age categories from 1 to 100 years. Journal of 
Neuropathology & Experimental Neurology, 70(11):960–969, 2011. 
4. Gandhi, R. (2018, July 05). Support Vector Machine - introduction to Machine Learning 
algorithms. Retrieved March 30, 2021, from https://towardsdatascience.com/support-vector-
machine-introduction-to-machine-learning-algorithms-934a444fca47 
5. Joseph E Gaugler, Lisa J Bain, Lauren Mitchell, Jessica Finlay, Sam Fazio, Eric Jutkowitz, 
Sube Banerjee, Kim Butrum, Joseph Gaugler, Laura Gitlin, et al. Reconsidering frameworks 
of Alzheimer’s dementia when assessing psychosocial outcomes. Alzheimer’s & Dementia: 
Translational Research& Clinical Interventions, 5:388–397, 2019. 
6. Brian A Gordon, Tyler M Blazey, Yi Su, Amrita Hari-Raj, Aylin Dincer, Shaney Flores, Jon 
Christensen, Eric McDade, Guoqiao Wang, Chengjie Xiong, et al. Spatial patterns of 
neuroimaging biomarker change in individuals from families with autosomal dominant 
Alzheimer’s disease: a longitudinal study. The Lancet Neurology, 17(3):241–250, 2018. 
28
SMU Data Science Review, Vol. 5 [2021], No. 1, Art. 5
https://scholar.smu.edu/datasciencereview/vol5/iss1/5
7. Gupta, P. (2017, November 12). Decision trees in Machine Learning. Retrieved March 30, 
2021, from https://towardsdatascience.com/decision-trees-in-machine-learning-
641b9c4e8052 
8. Peter Harrington. Machine Learning in action. Manning Publications Co.,2012.  
9. Liesi E Hebert, Jennifer Weuve, Paul A Scherr, and Denis A Evans. Alzheimer disease in the 
united states (2010–2050) estimated using the2010 census. Neurology, 80(19):1778–1783, 
2013. 
10. Michael D Hurd, Paco Martorell, Adeline Delavande, Kathleen J Mullen, and Kenneth M 
Langa. Monetary costs of dementia in the united states. New England Journal of Medicine, 
368(14):1326–1334, 2013.  
11. Clifford R Jack Jr, Val J Lowe, Stephen D Weigand, Heather J Wiste, Matthew L Senjem, 
David S Knopman, Maria M Shiung, Jeffrey L Gunter, Bradley F Boeve, Bradley J Kemp, et 
al. Serial pib and mri in normal, mild cognitive impairment and Alzheimer’s disease: 
implications for sequence of pathological events in Alzheimer’s disease. Brain, 132(5):1355–
1365, 2009. 
12. Gareth James, Daniela Witten, Trevor Hastie, and Robert Tibshirani. An 
introduction to statistical learning (vol. 112, p. 18), 2013. 
13. Leigh A Johnson, Melissa Edwards, Adriana Gamboa, James Hall, Michelle Robinson, and 
Sid E O’Bryant. Depression, inflammation, and memory loss among mexican americans: 
analysis of the hable cohort. International Psychogeriatrics, 29(10):1693–1699, 2017. 
14. Eric Jutkowitz, Robert L Kane, Joseph E Gaugler, Richard F MacLehose, Bryan Dowd, and 
Karen M Kuntz. Societal and family lifetime cost of dementia: implications for policy. 
Journal of the American Geriatrics Society,65(10):2169–2175, 2017.  
15. Max Kuhn, Kjell Johnson, et al. Applied predictive modeling, volume 26. Springer, 2013.  
16. Jodi Liu, Jakub Hlávka, Richard John Hillestad, and Soeren Mattke. Assessing the 
preparedness of the US health care system infrastructure for an Alzheimer’s treatment. 
RAND, 2017.  
17. Thomas H McCoy Jr, Sheng Yu, Kamber L Hart, Victor M Castro, Han-nah E Brown, James 
N Rosenquist, Alysa E Doyle, Pieter J Vuijk, Tianxi Cai, and Roy H Perlis. High throughput 
phenotyping for dimensional psychopathology in Electronic Health Records. Biological 
psychiatry, 83(12):997–1004, 2018.  
18. Thomas H McCoy Jr, Larry Han, Amelia M Pellegrini, Rudolph E Tanzi, Sabina Berretta, 
and Roy H Perlis. Stratifying risk for dementia onset using large-scale Electronic Health 
Record data: a retrospective cohort study. Alzheimer’s & Dementia, 2019. 
19. Vollmer, S., Mateen, B. A., Bohner, G., Király, F. J., Ghani, R., Jonsson, P., ... & 
Hemingway, H. (2020). Machine Learning and artificial intelligence research for patient 
benefit: 20 critical questions on transparency, replicability, ethics, and 
effectiveness. bmj, 368, 2020. 
20. George A Miller. Wordnet-about us. wordnet. princeton university. 2009, 2010. 
21. The Office of the National Coordinator for Health Information Technology. 2018 report to 
congress, annual update on the adoption of a nationwide system for electronic use and 
exchange of health information, 2018, from 
https://www.healthit.gov/sites/default/files/page/2018-12/2018-HITECH-report-to-
congress.pdf. 
22. National Institute on Aging. Basics of Alzheimer’s disease and dementia: What is 
Alzheimer’s disease? 2017. URLhttps://www.nia.nih.gov/health/what-alzheimers-disease. 
23. Ji Hwan Park, Han Eol Cho, Jong Hun Kim, Melanie M Wall, Yaakov Stern, Hyunsun Lim, 
Shinjae Yoo, Hyoung Seop Kim, and Jiook Cha. Machine Learning prediction of incidence 
of Alzheimer’s disease using large-scale administrative health data. NPJ digital medicine, 
3(1):1–7, 2020. 
24. Xiaogang Peng and Ben Choi. Document classifications based on word semantic hierarchies. 
In Artificial Intelligence and Applications, volume 5, pages 362–367. Citeseer, 2005. 
29
Stephan et al.: Rule out Screening for Undiagnosed Dementia and Alzheimer’s Disease
Published by SMU Scholar, 2021
25. Fred Ramsey and Daniel Schafer. The statistical sleuth: a course in methods of data analysis. 
Cengage Learning, 2012. 
26.  https://www.hcup-us.ahrq.gov/toolssoftware/ccsr/ccs_refined.jsp#overdiagnoses 
27. Eric M Reiman, Yakeel T Quiroz, Adam S Fleisher, Kewei Chen, Carlos Velez-Pardo, 
Marlene Jimenez-Del-Rio, Anne M Fagan, Aarti R Shah, Sergio Alvarez, Andrés Arbelaez, 
et al. Brain abnormalities in young adults at genetic risk for autosomal dominant Alzheimer’s 
disease: a cross-sectional study. The Lancet. Neurology, 11(12):1048, 2012. 
28. Dipanjan Sarkar. Text analytics with python: A practical real-world approach to gaining 
actionable insights from your data. New York: Apress;2016. 
29. Yiu, T. (2019, August 14). Understanding Random Forest. Retrieved March 30, 2021, from 
https://towardsdatascience.com/understanding-random-forest-58381e0602d2 
30. Pulia, M. S., O’Brien, T. P., Hou, P. C., Schuman, A., & Sambursky, R. Multi-tiered 
screening and diagnosis strategy for COVID-19: a model for sustainable testing capacity in 
response to pandemic. Annals of medicine, 52(5), 207-214, 2020. 
31. Esserman, L. J., Shieh, Y., Park, J. W., & Ozanne, E. M. A role for biomarkers in the 
screening and diagnosis of breast cancer in younger women. Expert review of molecular 










SMU Data Science Review, Vol. 5 [2021], No. 1, Art. 5
https://scholar.smu.edu/datasciencereview/vol5/iss1/5
